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The Voyages of Zika Virus 
 
The announcement in May this year from the World Health Organization, that the Zika virus 
outbreak that began in October 2015 in the Cape Verde Islands off the west coast of Africa, 
was an American variant of Zika virus, confirmed that Zika has now circumnavigated the 
world.  Unlike the first human circumnavigators in the 16th century, who sailed the world 
from east to west, Zika travelled in the opposite direction, heading east out of Africa to 
south-east Asia, then across the Pacific Ocean, through the Americas and finally back across 
the Atlantic to Africa.  Zika was discovered by accident in 1947 in macaque monkeys caged 
in Uganda’s Zika forest as part of a yellow fever monitoring study.  A relative of yellow fever 
in the genus Flavivirus, and spread in much the same way by mosquitoes of the genus 
Aedes, Zika simply joined the growing list of obscure tropical viruses of no clinical 
importance, registering barely a dozen mild cases of fever and rash in humans over the next 
sixty years.   
 
Obscure no more 
 
Then in 2007, the isolated Micronesian island of Yap became the location of the first 
epidemic in humans.  Subsequent serological investigation showed that the majority of the 
population of a few thousand were infected, and that most of them reported no symptoms.  
Zika’s potential for disseminated transmission was amply illustrated, but it wasn’t until 2013 
that the clinical implications of this became clearer.  In that year, an even bigger outbreak 
occurred in Polynesia, infecting tens of thousands and adding an unwelcome new symptom 
to Zika’s clinical description – Guillain-Barré syndrome, an auto-immune paralysis.  Even 
then, there were no fatalities, and it wasn’t until Zika completed the trans-Pacific leg of its 
journey, arriving in Brazil during or before the 2014 World Cup, a wave of foetal 
microcephaly cases trailing 9 months in its wake, that the world finally realised the 
seriousness of this new pandemic, with the WHO declaring a Public Health Emergency of 
International Concern (PHEIC) on 1st February 2016. 
 
Out of Africa 
 
Why Zika should suddenly cause so much trouble after decades, perhaps centuries, of 
obscurity, remains a mystery.  We have good grounds to believe that Zika originated in 
Africa, for the classic population genetic reason – which also applies to HIV and HCV – that 
the African strains are more genetically diverse than the non-African ones, indicating an 
accumulation of variation over a longer period of time.  Diversity within the Asian and 
American strains is comparatively small and Bayesian phylogenetic analyses have dated 
Zika’s emergence from Africa in the early-to-mid-20th century.  Zika’s sporadic appearances 
in Africa have been in a belt from Uganda, through the Central African Republic to Nigeria 
and Senegal in the west, and its first isolation outside of Africa was in Malaysia in the 1960s.  
Just as earlier slave trade movements probably exported Zika’s relative yellow fever from 
Africa across the Atlantic to the Americas, it is easy to imagine later colonial migrations, 
possibly administrative, commercial or military, carrying Zika from the British colonies in 
east Africa to those in south-east Asia.  The fact that it didn’t reach the Americas along with 
yellow fever in the 18th century suggests that Zika was rare in west Africa at that time, and 
indeed we have no up-to-date information on Zika’s incidence in Africa now, except for a 
handful of serological studies conducted mostly before 1980 which suggest that between 
6% and 60% of the African population are exposed to Zika at some point in their lives.  In 
Asia, the corresponding figures are lower, less than 15% at all tested sites, again consistent 




Increased virulence or lack of herd immunity? 
 
We cannot currently reconstruct much concerning Zika’s pre-history until we can obtain 
more genome sequences from both Africa and Asia, and Zika is so far proving a difficult virus 
to isolate and sequence.  A short viraemia and odd compositional content mean that we 
simply aren’t accumulating genomes as fast as we did with Ebola at the height of the west 
African outbreak in 2014-2015.  To a certain extent, however, quality is better than quantity.  
Most of the Brazilian and other Latin American Zika genomes are very similar, and the really 
interesting differences are likely to occur away from the leaves of the phylogenetic tree and 
down in the branches where Asian Zika diversified before setting off across the Pacific.  Here 
is where the crucial genetic differences will be found if it is the case that Pacific/American 
Zika’s apparently novel properties – wider range of symptoms, possibly a greater 
transmissibility, Guillain-Barré and microcephaly associations – are due to evolution of the 
virus.  On the other hand, it is perfectly possible that strain differences are inconsequential 
genetic drift and that what we are really seeing in the Americas is simply yet another 
example of an introduced pathogen wreaking havoc in a population with no previous 
exposure.  The Native Americans of colonial times suffered terribly from the introduction of 
smallpox, influenza, yellow fever and even cold viruses from the Old World, and Zika may 
simply be doing what many viruses tend to do when they enter a host population with no 
herd immunity. 
 
What now for Africa? 
 
The answer to this question will also have consequences for Africa.  The Zika outbreak in the 
Cape Verde Islands is confirmed by the WHO as being of Brazilian origin, and has been 
associated with microcephaly.  If the islanders have never been exposed to Zika before, we 
might regard this as a similar situation to Brazil.  On the other hand, if African Zika has 
circulated in Cape Verde, we must wonder why it has not produced a cross-protective effect 
against the American strain.  A crucial test will be what happens in Guinea-Bissau, the first 
mainland African country to report an outbreak in recent times, and like Cape Verde and 
Brazil, a former Portuguese colony.  This cultural link suggests that Guinea-Bissau might 
have American Zika, in which case what happens there may forewarn us of what might 
happen elsewhere in Africa.  We may soon have an indication from the macaque monkey 
model of Zika infection used in the vaccine development programme.  The current 
experimental Zika vaccine is based on American strains (Brazilian and Puerto Rican) so if it 
protects against infection with an African strain, the converse will probably apply and we 
are unlikely to see a similar epidemic of microcephaly in Africa as we have recently seen 
across tropical Latin America. 
 
Zika Down Under 
 
Meanwhile, Zika continues to be detected more sporadically in south-east Asia.  The lower 
epidemiological intensity and absence, so far, of microcephaly complications suggests that 
south-east Asia, perhaps like Africa, has the herd immunity that the Pacific and Americas 
lack.  Since climate of Indonesia, and also some Aedes mosquito species, is shared by the 
tropical northern Australian coast, Zika might have been expected to have already arrived in 
Australia.  However, what is different is the absence of a wild monkey species in Australia, 
which may deprive Zika of the animal reservoir it needs to maintain itself in an area where 
the human population is mostly immune.  In Africa, red-tailed monkeys have been shown to 
be a Zika reservoir, and in Brazil, Zika has already been detected in marmosets and 
capuchins.  Of course, Australia, like all countries, could also see Zika spread by sexual 
transmission.  This is climate and mosquito-independent, but we still have no idea if it is 
sustainable. 
 
